跳至主要内容
临床试验/TCTR20140901001
TCTR20140901001已完成4 期

se of brain perfusion SPECT to determine responder to choline esterase inhibitor to reduce national therapeutic cost

government0 个研究点目标入组 60 人开始时间: 2014年9月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
50 Years 至 0 Years(—)
性别
All

入选标准

  • Diagnosis of probable Alzheimer's disease by NINCDS/ADRDA criteria, mild to moderate degree

排除标准

  • Severe head trauma, delirium, depression, other known neuro-psychologic diseases, COPD, asthma, sik sinus syndrome, ischemic heart disease, peptic ulcer, history of gastrointestinal bleeding, type I DM, had received choline esterase inhibitors or nicergoline or other research drugs within 1 month before the study, alcohol or drug abuse, during treatment with NSAIDs, anticholinergic, carrbamazepine, dexamethasone, phenobarbital, ketoconazole

研究者

发起方
government

相似试验